Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: The Power of the Placebo

Simon M. Helfgott, MD  |  Issue: October 2013  |  October 1, 2013

Harnessing the Placebo Effect

When we discuss therapeutic options with patients, it is critical that we frame our conversations carefully. For a moment, consider these discussions from the patient’s point of view. The reams of drug information material that we provide them, the lengthy printouts attached to the prescription bottles, the side-effect warnings at the end of each television ad, all sound an ominous tone: these drugs can hurt, or even harm, you. The sheer number of side effects that are listed can drown out any of the positive attributes of a treatment or a drug. Yet, we cannot return to the days of paternalistic medicine when “doctors knew best” and saw little need to be honest and forthright with patients about their illnesses and their treatments.

We must remember that our words, attitudes, and behaviors play dominant roles in both the doctor–patient interaction and in the placebo response. Altruism, empathy, and compassionate behavior emerged sometime during the course of human evolution. It is postulated that facial expressions are likely to have evolved for eliciting medical attention from others.10 These expressions of pain were thought to trigger the caregiver’s empathic and compassionate behavior. Yes, we can be honest and compassionate at the same time. We may not win over every patient’s heart and mind, but exuding a quiet confidence, a steady determination and sense of concern will help many of those seeking our help. After all, that seems to be the way we are wired.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Helfgott is physician editor of The Rheumatologist and associate professor of medicine in the division of rheumatology, immunology, and allergy at Harvard Medical School in Boston.

References

  1. O’Connor A. The claim: Raisins soaked in gin can ease arthritis pain. Published October 3, 2006. Available at www.nytimes.com/2006/10/03/health/03real.html. Accessed September 13, 2013.
  2. Collins L. The third man. New Yorker. Published September 2, 2013. Available at www.newyorker.com/reporting/2013/09/02/130902fa_fact_collins. Accessed September 13, 2013.
  3. Finnissa DG, Kaptchuk TJ, Miller F, et al. Placebo effects: Biological, clinical and ethical advances. Lancet. 2010;375:686-695.
  4. Kaptchuk TJ, Kerr CE, Zanger A. Placebo controls, exorcisms and the devil. Lancet. 2009;374:1234-1239.
  5. Brown WA. The Placebo Effect in Clinical Practice. Oxford University Press: New York, 2012
  6. Elsenbruch S, Kotsis V, Benson S, et al. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia. An fMRI study in healthy placebo responders and nonresponders. Pain. 2012;153:382-390.
  7. Carl Sagan. The Demon-Haunted World: Science as a Candle in the Dark. Random House: New York, 1995.
  8. Barsky AJ, Saintfort P, Rogers MP, et al. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622-627.
  9. Myers MG, Cairns JA, Singer J. The consent form as a possible cause of side effects. Clin Pharmacol Ther. 1987;42:250-253.
  10. Benedetti F. Placebo and the new physiology of the doctor–patient relationship. Physiol Rev. 2013;93:1207-1246.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:patient careplaceborheumatology

Related Articles

    What Diet to Recommend to Patients with Rheumatoid Arthritis?

    November 1, 2013

    With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

    Diagnostic Tests, Tips for Gluten-Induced Celiac Disease

    June 13, 2016

    CHICAGO—Celiac disease—the gluten-induced illness that can be seen alongside rheumatic diseases—has been seen much more commonly over the past 20 years than it was previously, but the illness can come with questions that are not always straightforward, an expert said at the ACR’s State-of-the-Art Clinical Symposium. The disease, in which the small intestine becomes inflamed…

    Diet May Help Reduce Inflammation in RA

    March 27, 2023

    In a small study, an anti-inflammatory diet helped reduce pain and swelling in a subset of people with rheumatoid arthritis (RA). Diet changes are complementary to standard treatment. Diet-related research can be challenging, but many patients with RA are motivated to try healthy changes.

    The Role of T Cells in Celiac Disease

    April 17, 2017

    Celiac is an autoimmune disease with both gastrointestinal and neurological implications. A recent review examined the immunological research on celiac disease to date, detailing the role of T cells and the protein TG2 in disease pathology…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences